- Home
- QLGN vs BKYI Comparison
QLGN vs BKYI Comparison
Compare QLGN & BKYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QLGN
- BKYI
- Stock Information
- Founded
- QLGN 1996
- BKYI 1993
- Country
- QLGN United States
- BKYI United States
- Employees
- QLGN 4
- BKYI N/A
- Industry
- QLGN Biotechnology: Pharmaceutical Preparations
- BKYI Computer Software: Prepackaged Software
- Sector
- QLGN Health Care
- BKYI Technology
- Exchange
- QLGN Nasdaq
- BKYI Nasdaq
- Market Cap
- QLGN 2.7M
- BKYI 3.2M
- IPO Year
- QLGN N/A
- BKYI 1997
- Fundamental
- Price
- QLGN $3.60
- BKYI $0.94
- Analyst Decision
- QLGN
- BKYI
- Analyst Count
- QLGN 0
- BKYI 0
- Target Price
- QLGN N/A
- BKYI N/A
- AVG Volume (30 Days)
- QLGN 226.0K
- BKYI 6.3M
- Earning Date
- QLGN 11-29-2024
- BKYI 11-14-2024
- Dividend Yield
- QLGN N/A
- BKYI N/A
- EPS Growth
- QLGN N/A
- BKYI N/A
- EPS
- QLGN N/A
- BKYI N/A
- Revenue
- QLGN N/A
- BKYI $7,292,394.00
- Revenue This Year
- QLGN N/A
- BKYI N/A
- Revenue Next Year
- QLGN N/A
- BKYI $24.64
- P/E Ratio
- QLGN N/A
- BKYI N/A
- Revenue Growth
- QLGN N/A
- BKYI N/A
- 52 Week Low
- QLGN $3.55
- BKYI $0.52
- 52 Week High
- QLGN $39.15
- BKYI $4.50
- Technical
- Relative Strength Index (RSI)
- QLGN 25.42
- BKYI 45.22
- Support Level
- QLGN $3.71
- BKYI $1.13
- Resistance Level
- QLGN $4.56
- BKYI $1.31
- Average True Range (ATR)
- QLGN 0.65
- BKYI 0.17
- MACD
- QLGN -0.06
- BKYI -0.01
- Stochastic Oscillator
- QLGN 2.08
- BKYI 1.93
About QLGN Qualigen Therapeutics Inc.
Qualigen Therapeutics Inc is a early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program. The company's lead program, QN-302, is an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor with strong binding affinity to G4s prevalent in cancer cells.
About BKYI BIO-key International Inc.
BIO-key International Inc is a fingerprint biometric technology company. It develops and markets fingerprint biometric identification and identity verification technologies, as well as related identity management and credentialing hardware and software solutions. Its product portfolio comprises SideSwipe, SidePass, EcoID, WEB-key, and others. The company generates its revenue in the form of Services, License fees, and others.